TY - JOUR
T1 - Landelijke richtlijnen voor follow-up van overlevenden van kinderkanker
AU - Kremer, L. C.M.
AU - Jaspers, M. W.M.
AU - Van Leeuwen, F. E.
AU - Versluys, A. B.
AU - Bresters, D.
AU - Bökkerink, J. P.M.
AU - Hakvoort-Cammel, F. G.A.J.
AU - Postma, A.
AU - Schouten-Van Meeteren, A. Y.N.
AU - Van Dulmen-Den Broeder, E.
AU - Van Der Pal, H. J.H.
AU - Hazelhoff, J.
AU - Ronckers, C. M.
AU - Van Dam, E. W.C.M.
AU - Braam, K. I.
AU - Van Der Linden, G. H.M.
AU - Blaauwbroek, R.
AU - De Ridder-Sluiter, J. G.
AU - Van Den Bos, C.
PY - 2006/12/1
Y1 - 2006/12/1
N2 - Members of the Late Effects Taskforce of the Dutch Childhood Oncology Group (DCOG) and of the Haematology-Oncology Section of the Dutch Paediatric Association are involved in the development of guidelines for the follow-up of childhood cancer survivors. The recommendations of these guidelines are based on the best available clinical evidence, current guidelines and clinical experience of late effects specialists. The guidelines will lead to a uniform and standardised post-treatment care and long-term follow-up of childhood cancer survivors in the Netherlands. The information in the guidelines will be of importance for care providers in paediatrics, general medicine, internal medicine, gynaecology/obstetrics as well as for other specialists and particularly for childhood cancer survivors themselves. The information will lead to an increased awareness for all Dutch care providers who are responsible for the health problems of childhood cancer survivors. The development of guidelines for childhood cancer survivors is an important part of a new Dutch project: Late Effects Registry (LATER). Within this new national project patient and treatment data as well as follow-up data on childhood cancer survivors in the Netherlands will be registered. The project LATER aims at: to coordinate and to evaluate care of the survivors, and to stimulate new research in the field of late effects of childhood cancer.
AB - Members of the Late Effects Taskforce of the Dutch Childhood Oncology Group (DCOG) and of the Haematology-Oncology Section of the Dutch Paediatric Association are involved in the development of guidelines for the follow-up of childhood cancer survivors. The recommendations of these guidelines are based on the best available clinical evidence, current guidelines and clinical experience of late effects specialists. The guidelines will lead to a uniform and standardised post-treatment care and long-term follow-up of childhood cancer survivors in the Netherlands. The information in the guidelines will be of importance for care providers in paediatrics, general medicine, internal medicine, gynaecology/obstetrics as well as for other specialists and particularly for childhood cancer survivors themselves. The information will lead to an increased awareness for all Dutch care providers who are responsible for the health problems of childhood cancer survivors. The development of guidelines for childhood cancer survivors is an important part of a new Dutch project: Late Effects Registry (LATER). Within this new national project patient and treatment data as well as follow-up data on childhood cancer survivors in the Netherlands will be registered. The project LATER aims at: to coordinate and to evaluate care of the survivors, and to stimulate new research in the field of late effects of childhood cancer.
UR - http://www.scopus.com/inward/record.url?scp=33846596792&partnerID=8YFLogxK
M3 - Article
SN - 0376-7442
VL - 74
SP - 214
EP - 218
JO - Tijdschrift voor kindergeneeskunde
JF - Tijdschrift voor kindergeneeskunde
IS - 6
ER -